Aseel M. Al Dayyeni et al. 2023. The prevalence of JAK2, CALR, and MPL mutations in BCR-ABL1 rearrangement negative Iraqi patients. Journal of Population Therapeutics and Clinical Pharmacology. 30, 3 (Mar. 2023), 443–451. DOI:https://doi.org/10.47750/jptcp.2023.30.03.046.